Return On Equity	(Dec 31 2019) 2019	(Dec 31 2018) 2018	(Dec 31 2017) 2017	(Dec 31 2016) 2016	(Dec 31 2015) 2015
Y / Y Equity Change	-80.93 %	34.37 %	-47.22 %	28.95 %	106.72 %
Y / Y Net Income Change	28.34 %	12.86 %	124.01 %	77.61 %	43.83 %
Return On Equity	541.55 %	80.45 %	95.79 %	22.57 %	16.39 %

FOMX all Ratios >> Back to FOMX Management Effectiveness >> See Quarterly FOMX Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Dec 31 2019) ROE improved to 541.55 % compare to previous year, due to net income growth.

Financial Statements
Foamix Pharmaceuticals Ltd 's Equity	$ 18 Millions	Annual FOMX's Balance sheet
Foamix Pharmaceuticals Ltd 's Annual Income	$ 95 Millions	Annual FOMX's Income Statement
Where are FOMX's Income coming from?		Visit FOMX's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.